Brief: Conmed Q3 Adjusted EPS USD 1.08 Vs. IBES Estimate USD 1.05
05/11/2025 21:05
Nov 05 (Reuters) - Conmed Q3 sales USD 337.926 million vs. IBES estimate USD 334.8 million. Q3 income from operations USD 11.879 million Q3 net income USD 2.859 million Q3 pretax profit USD 4.273 million Q3 EPS USD 0.09 outlook FY revenue USD 1,365-1,372 million outlook FY adjusted EPS USD 4.48-4.53
Recent news on Conmed
See all newsU.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Conmed Corp reports results for the quarter ended June 30 - Earnings Summary
Conmed Q2 sales, adjusted profit beat on organinc platform growth
Brief: Conmed Q2 Adjusted EPS USD 1.38 Vs. IBES Estimate USD 1.11
Brief: Conmed Is Said To Weigh Sale After Takeover Interest- Bloomberg News